ArticleSports medicine - open2026
The Omega-3 Index and Self-Reported Dietary Intake of DHA and EPA in Highly Trained, Elite and World Class (Tier 3-5) Male and Female Athletes: An Australian Based Cross-sectional Study.
Article in Sports medicine - open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong-chain omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) support cardiovascular health; however, athletes often exhibit Omega-3 Index (O3I) levels below 8%, a threshold associated with reduced cardiovascular disease (CVD) risk, suggesting insufficient dietary intake of DHA and EPA. Therefore, the objective of this study was to characterise the O3I, dietary intake of DHA and EPA, and supplement use in a large cohort of highly trained, elite and world class (Tier 3-5) Australian based athletes.
methodsIn this multi-site cross-sectional study, 595 male and female athletes (18-45 years) from 17 sports provided a dried blood spot for whole blood fatty acid analysis and completed a dietary survey. The O3I was derived using a validated conversion algorithm. Dietary DHA and EPA intake was assessed using a marine food frequency questionnaire. Group comparisons were conducted using Mann-Whitney U and independent-samples t-tests, and differences across intake quartiles were assessed using Kruskal-Wallis tests.
resultsMean (SD) O3I was 5.88 ± 1.40%, with 3% of athletes < 4%, 60% between 4-6%, 30% between 6-8%, and only 7% ≥ 8%. O3I increased across DHA + EPA intake quartiles (p < 0.001) and was higher in males than females (p < 0.01). Athletes reporting omega-3 supplement use (19%) had higher O3I (Median [IQR]) compared with non-users (7.02 [6.28-8.01%] vs 5.38 [4.82-6.02%]; p < 0.001). Median total daily DHA + EPA intake was 261 mg/day, with 72% of athletes consuming < 500 mg/day. Daily whole-food intake of DHA + EPA was modest and did not differ by sex.
conclusionMost athletes based in Australia had O3I below the ≥ 8% CVD risk reduction threshold, highlighting opportunities for organisations and sporting bodies to support initiatives that increase DHA and EPA intake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.